Jane Street Group, LLC Onconova Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$0.57 - $1.0 $14,285 - $25,062
25,062 New
25,062 $14,000
Q1 2023

May 15, 2023
SELL
$0.69 - $1.42 $3,345 - $6,884
-4,848 Reduced 31.99%
10,308 $7,000
Q4 2022

Feb 14, 2023
BUY
$0.63 - $0.97 $9,548 - $14,701
15,156 New
15,156 $9,000
Q2 2022

Aug 16, 2022
BUY
$1.04 - $1.9 $15,576 - $28,456
14,977 New
14,977 $20,000

Others Institutions Holding ONTX

# of Institutions
3
Shares Held
249K
Call Options Held
0
Put Options Held
0
View Full List

About Onconova Therapeutics, Inc.

ONTX Quotes by TradingView
  • Ticker ONTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,895,600
  • Market Cap $12.3M
  • Description
  • Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...
More about ONTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email